Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

OTCQX:MRVFF - Post Discussion

Nuvo Pharmaceuticals Inc > Valuation
View:
Post by lscfa on Jan 29, 2021 10:04am

Valuation

Still cheaper than peers../

 

 

Nuvo

Nuvo 

Medexus

2021 ebitda 

22.6

22.6

15.1

Multiple

6.5

11.0

11

Ent value

146.9

248.6

166.1

Net debt

115.6

115.6

54.6

Mkt cap

31.3

133.0

111.5

Shs o/s

11.4

40.0

14.5

Share value

$2.75

$3.33

$7.69

Comment by lscfa on Jan 29, 2021 10:18am
Corrected table.....       Nuvo Nuvo  Medexus 2021 ebitda  22.6 22.6 15.1 Multiple 6.5 11.0 11 Ent value  ...more  
Comment by lscfa on Jan 29, 2021 10:43am
another comparison....     Q3 2020 Nuvo Medexus Cash flow ops 5,160 2,263 Ave Shs o/s 11,388 14,454 Qtrly cfps $0.453 $0.157 ...more  
Comment by lscfa on Jan 30, 2021 4:07pm
Another comparison....   Nuvo Sept 20 Jun 20 Mar 20 Revenue 16,669 18,046 18,913 adj ebitda 6,565 7,646 7,990   39 ...more  
Comment by BullBoyMoon on Jan 29, 2021 10:44am
Unbelievable!! I'm glad I own this!
Nuvo Pharmaceuticals Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities